A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial

Clinical trial NCT05670470 · COMPLETED

Trial details

NCT number: NCT05670470
Sponsor: Taejoon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bowel Preparation

Start date: 2022-09-21
Primary completion: 2023-01-15
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.